Brief: Bio-Rad Q2 Adjusted EPS USD 3.11 Vs. IBES Estimate USD 2.01
01/08/2024 21:15
Aug 01 (Reuters) - Bio-Rad Q2 sales USD 638.5 million vs. IBES estimate USD 645.8 million. * Q2 net income USD -2,165.5 million * Q2 gross margin 55.6% * Q2 EBIT margin 15.9% * Q2 EPS USD -76.26
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A